Search Results for 'FDA'

Each year, tens of thousands of people in Ireland undergo radiation therapy as part of their cancer treatment. A life-saving intervention, radiation therapy plays a vital role in improving survival. But for some, the effects of radiation don’t end with treatment.

Ireland has one of the highest rates of type 2 diabetes in Europe, with more than 225,000 people currently diagnosed. Among the most serious complications are diabetic foot ulcers (DFUs). DFUs are wounds that are slow to heal, and around 15 per cent of people with diabetes will develop a DFU during their lifetime. DFUs can significantly impact quality of life, and, in some cases, result in admission to hospital or amputation.

Galway-based connected health start-up, FeelTect, has announced the commercial launch of its pioneering wound care device, Tight Alright, starting in Thun Hospital, Switzerland. The commercial launch coincides with the successful close of a €1.5 million investment round involving Irrus Investments, the Western Development Commission (WDC), and a network of angel investors.?

A consortium led by University of Galway spin-out Fortis Medical Devices has secured a €2.1 million government grant to accelerate the development of breakthrough stroke rehabilitation technology.

125 jobs are to be created over the next three years at Oranmore-based Neurent Medical, a rapidly growing innovator in ear, nose, and throat (ENT) healthcare solutions.

VERSONO Medical Ltd has been named Dragons’ Den winner of the CX Innovation Prize at the international CX Symposium in London.

Galway-based medical device company Nua Surgical has announced the closure of its €6.5 million funding round for its innovative SteriCISION® C-Section Retractor.

Parkmore-based VERSONO® Medical Ltd has begun enrolling patients in the FREEFLOW pivotal study for its FastWire System. FastWire is a truly disruptive technology designed to quickly access previously untreatable complex blockages in arteries, increasing success rates and reducing risk of amputations via endovascular techniques.

Parkmore-based VERSONO® Medical Ltd has begun enrolling patients in the FREEFLOW pivotal study for its FastWire System. FastWire is a truly disruptive technology designed to quickly access previously untreatable complex blockages in arteries, increasing success rates and reducing risk of amputations via endovascular techniques.

Chez Elaine, leaders of non-invasive face and body advanced aesthetic therapies, are delighted to announce their EMSUITE 'Open House Event' on Thursday, November 7, and Friday, November 8, a date for your diary that you don’t want to miss.